MIDEQ – Microneedling and Intradermal Dispensing of Exact Quantities

01 September 2021 → 31 March 2024
Regional and community funding: Industrial Research Fund
Research disciplines
  • Medical and health sciences
    • Dermatochirurgy and cosmetic treatment
    • Plastic surgery
    • Dermatology
    • Medical device usage
  • Engineering and technology
    • Mechanical drive systems
    • Microfabrication and manufacturing
    • Hydrodynamics
Aesthetic medicine dermatology burn surgery plastic surgery intra-dermal drug delivery
Project description

Intradermal injections of injectables such as botulinum toxin (botox), hyaluronic acid and platelet-rich plasma are one of the most performed procedures globally. In 2019, over  10 million aesthetic injection procedures were performed by plastic surgeons alone. Despite the multitude of available devices, most are inefficient, thus wasting valuable time and money. To overcome the current shortcomings, MIDEQ was conceptualized. Invented at Ghent University, MIDEQ aims to make procedures shorter by at least 50%, while simultaneously ensuring no drug loss, thereby saving money for the patient while generating additional income for the practitioner. The device consists of 2 main components, a reusable motor unit and a disposable set, containing a uniquely designed needling cartridge. The aim of this StarTT project is to establish technical Proof of Concept through extensive testing on ex vivo human waste material. Simultaneously, the existing IP will be strengthened and the valorization strategy will be crafted.